Novavax, Inc. has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovidtm to Sanofi, enabling Sanofi to take full responsibility for commercial and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback